81% rise in Victoza sales drives Novo Nordisk earnings

Article Date: 27/04/2012 10:33
81% rise in Victoza sales drives Novo Nordisk earnings

Vacancy Search

Quick job search

Advanced Search

Latest News

Eisai's Lenvima breakthrough therapy for new indication

Eisai's Lenvima breakthrough therapy for new indication

Sanofi diabetes combo meets Phase III goal

Sanofi diabetes combo meets Phase III goal

Merck acquires immune-oncology specialist cCAM

Merck acquires immune-oncology specialist cCAM

Trio of Novartis castoffs is just the beginning for Mereo

Novartis might have deemed BPS804, BCT197 and BGS649 excess to requirements, but the trio of phase II assets has given life to a brand new UK biotech company, Mereo Biopharma, launched today...

Sanofi dengue vaccine shows promise in older children

Sanofi dengue vaccine shows promise in older children

Sanofi and Regeneron look to break into immunotherapy

Sanofi and Regeneron look to break into immunotherapy

Accelerated EU review for Takeda multiple myeloma drug

Accelerated EU review for Takeda multiple myeloma drug

Teva confirms $40.5bn offer to buy Allergan generics

Teva confirms $40.5bn offer to buy Allergan generics

Novartis melanoma, anaemia drugs win CHMP favour

Novartis melanoma, anaemia drugs win CHMP favour

Positive results for Alzheimer's app

Positive results for Alzheimer's app
more news